palmidrol has been researched along with tyrosine in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 11 (91.67) | 24.3611 |
2020's | 1 (8.33) | 2.80 |
Authors | Studies |
---|---|
Kumar, A; Kumar, P; Qiao, Z; Song, ZH | 1 |
Aloisi, C; Cappellani, A; Cuzzocrea, S; Di Paola, R; Esposito, E; Impellizzeri, D; Mondello, P; Velardi, E | 1 |
Avagliano, C; Calignano, A; Citraro, R; Cosco, D; D'Agostino, G; De Sarro, G; Di Marzo, V; Gatta, L; Guida, F; Maione, S; Petrosino, S; Russo, E; Russo, R; Scicchitano, F; van Luijtelaar, G; van Rijn, CM | 1 |
Capoccia, E; Cipriano, M; De Filippis, D; Esposito, G; Iuvone, T; Negro, L; Sarnelli, G; Scuderi, C; Steardo, L | 1 |
Ahmad, A; Bruschetta, G; Crupi, R; Cuzzocrea, S; Di Paola, R; Esposito, E; Impellizzeri, D; Paterniti, I | 1 |
Ahmad, A; Bruschetta, G; Crupi, R; Cuzzocrea, S; Di Paola, R; Esposito, E; Impellizzeri, D; Paterniti, I; Prosdocimi, M; Siracusa, R | 1 |
Bruschetta, G; Campolo, M; Cordaro, M; Crupi, R; Cuzzocrea, S; Di Paola, R; Esposito, E; Fusco, R; Pugliatti, P; Siracusa, R | 1 |
Bruschetta, G; Cordaro, M; Crupi, R; Cuzzocrea, S; Esposito, E; Gugliandolo, E; Impellizzeri, D; Siracusa, R | 1 |
Cordaro, M; Crupi, R; Cuzzocrea, S; Esposito, E; Gugliandolo, E; Impellizzeri, D; Siracusa, R | 1 |
AlSharari, S; Bagdas, D; Donvito, G; Imad Damaj, M; Ivy Carroll, F; Jackson, A; Kulkarni, AR; Lichtman, AH; Meade, JA; Papke, RL; Rahimpour, E; Thakur, GA; Toma, W | 1 |
Abbas, MA; Aldaoud, N; Aldossary, SA; Alsalem, M; Altarifi, A; El-Salem, K; Haddad, M; Jaffal, SM; Kalbouneh, H | 1 |
Chen, W; Fang, H; Hong, Z; Jin, W; Li, L; Yang, L; Yi, Z; Zhang, G; Zhang, Y | 1 |
12 other study(ies) available for palmidrol and tyrosine
Article | Year |
---|---|
Effects of palmitoylethanolamide on aqueous humor outflow.
Topics: Amides; Animals; Aqueous Humor; Blotting, Western; Camphanes; Dose-Response Relationship, Drug; Endocannabinoids; Enzyme Activation; Ethanolamines; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Organ Culture Techniques; Oxazoles; Palmitic Acids; Phosphorylation; Piperidines; PPAR alpha; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, G-Protein-Coupled; Rimonabant; Swine; Trabecular Meshwork; Tyrosine | 2012 |
Palmitoylethanolamide reduces early renal dysfunction and injury caused by experimental ischemia and reperfusion in mice.
Topics: Amides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspartate Aminotransferases; Cell Adhesion Molecules; Endocannabinoids; Ethanolamines; gamma-Glutamyltransferase; Gene Expression Regulation; Kidney; Leukocytes; Mice; Mice, Knockout; Palmitic Acids; Poly Adenosine Diphosphate Ribose; PPAR alpha; Reperfusion Injury; Tyrosine | 2012 |
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy.
Topics: Amides; Animals; Anticonvulsants; Arachidonic Acids; Calcium Channel Blockers; Cannabinoid Receptor Antagonists; Dose-Response Relationship, Drug; Electroencephalography; Endocannabinoids; Epilepsy, Absence; Ethanolamines; Glycerides; Injections, Intraventricular; Lipid Metabolism; Male; Oxazoles; Palmitic Acids; Piperidines; Polyunsaturated Alkamides; PPAR alpha; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Tyrosine | 2013 |
Palmitoylethanolamide Regulates Production of Pro-Angiogenic Mediators in a Model of β Amyloid-Induced Astrogliosis In Vitro.
Topics: Adenosine Triphosphate; Amides; Amyloid beta-Peptides; Animals; Astrocytes; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Ethanolamines; Gliosis; Humans; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase Type II; Oxazoles; p38 Mitogen-Activated Protein Kinases; Palmitic Acids; Peptide Fragments; PPAR alpha; Rats; S100 Calcium Binding Protein beta Subunit; Tyrosine; Vascular Endothelial Growth Factor A | 2015 |
The anti-inflammatory effects of palmitoylethanolamide (PEA) on endotoxin-induced uveitis in rats.
Topics: Active Transport, Cell Nucleus; Amides; Animals; Anti-Inflammatory Agents; Dexamethasone; Disease Models, Animal; Endothelial Cells; Ethanolamines; Inflammation Mediators; Intercellular Adhesion Molecule-1; Lipid Peroxidation; Lipopolysaccharides; Male; Malondialdehyde; Neutrophil Infiltration; Nitric Oxide Synthase Type II; Palmitic Acids; Rats, Inbred Lew; Transcription Factor RelA; Tumor Necrosis Factor-alpha; Tyrosine; Uvea; Uveitis | 2015 |
Effects of palmitoylethanolamide and silymarin combination treatment in an animal model of kidney ischemia and reperfusion.
Topics: Active Transport, Cell Nucleus; Amides; Animals; Apoptosis; Cell Nucleus; Chymases; Cytokines; Disease Models, Animal; Disease Progression; Drug Interactions; Ethanolamines; Gene Expression Regulation; Kidney; Male; Mice; Nitrates; Nitrites; Oxidative Stress; Palmitic Acids; Reperfusion Injury; Risk Factors; Silymarin; Transcription Factor RelA; Tyrosine | 2015 |
Protective Effects of Ultramicronized Palmitoylethanolamide (PEA-um) in Myocardial Ischaemia and Reperfusion Injury in VIVO.
Topics: Amides; Animals; Ethanolamines; Immunohistochemistry; Intercellular Adhesion Molecule-1; Interleukin-1beta; Male; Mice; Mice, Knockout; Microtomy; Myocardial Ischemia; Myocardial Reperfusion Injury; P-Selectin; Palmitic Acids; PPAR alpha; Rats, Wistar; Tumor Necrosis Factor-alpha; Tyrosine | 2016 |
A new co-micronized composite containing palmitoylethanolamide and polydatin shows superior oral efficacy compared to their association in a rat paw model of carrageenan-induced inflammation.
Topics: Active Transport, Cell Nucleus; Administration, Oral; Amides; Animals; Carrageenan; Cell Line, Tumor; Cell Nucleus; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Drug Compounding; Drug Interactions; Edema; Ethanolamines; Gene Expression Regulation, Enzymologic; Glucosides; Hyperalgesia; Inflammation; Male; Neutrophil Infiltration; NF-KappaB Inhibitor alpha; Nitric Oxide Synthase Type II; Palmitic Acids; Proteolysis; Rats; Rats, Sprague-Dawley; Stilbenes; Superoxide Dismutase; Transcription Factor RelA; Tyrosine | 2016 |
Adelmidrol, a Palmitoylethanolamide Analogue, as a New Pharmacological Treatment for the Management of Inflammatory Bowel Disease.
Topics: Amides; Animals; Anti-Inflammatory Agents; Apoptosis; Body Weight; Colitis; Cyclooxygenase 2; Cytokines; Dicarboxylic Acids; Dinitrofluorobenzene; Ethanolamines; Extracellular Signal-Regulated MAP Kinases; Inflammatory Bowel Diseases; Intercellular Adhesion Molecule-1; Lipid Peroxidation; Male; Mice; NF-kappa B; P-Selectin; Palmitic Acids; Peroxidase; Phosphorylation; PPAR alpha; PPAR gamma; Receptor, Cannabinoid, CB2; Signal Transduction; Tyrosine | 2016 |
The interaction between alpha 7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α represents a new antinociceptive signaling pathway in mice.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Amides; Animals; Azabicyclo Compounds; Benzamides; Bridged Bicyclo Compounds; Cannabinoid Receptor Antagonists; Ethanolamines; Furans; Male; Mice; Mice, Inbred ICR; Nicotinic Antagonists; Nociception; Oxazoles; Pain Measurement; Palmitic Acids; PPAR alpha; Receptor Cross-Talk; Signal Transduction; Tyrosine | 2017 |
Role of cannabinoid receptor 1 and the peroxisome proliferator-activated receptor α in mediating anti-nociceptive effects of synthetic cannabinoids and a cannabinoid-like compound.
Topics: Amides; Analgesics; Animals; Cannabinoids; Dronabinol; Ethanolamines; Iodoacetic Acid; Male; Motor Activity; Osteoarthritis; Oxazoles; Palmitic Acids; PPAR alpha; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Tyrosine | 2019 |
Anti-Inflammatory Effects of Fucoxanthinol in LPS-Induced RAW264.7 Cells through the NAAA-PEA Pathway.
Topics: Amides; Amidohydrolases; Animals; Anti-Inflammatory Agents; beta Carotene; Cytokines; Enzyme Inhibitors; Ethanolamines; Inflammation; Lipopolysaccharides; Mice; Nitric Oxide; Oxazoles; Palmitic Acids; PPAR alpha; RAW 264.7 Cells; Tyrosine | 2020 |